|
1
|
Vijayamurugan N and Bakhshi S: Review of
management issues in relapsed osteosarcoma. Expert Rev Anticancer
Ther. 14:151–161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Liu Z, Jing P, Shao L, Chen L, He
X and Gong W: Effects of murine double minute 2 polymorphisms on
the risk and survival of osteosarcoma: A systemic review and
meta-analysis. Tumour Biol. 35:1649–1652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maeyama I: Review of bone tumor. Iryo.
24(Suppl): S2271970.(In Japanese).
|
|
4
|
Sanchez-Pareja A, Larousserie F,
Boudabbous S, Beaulieu JY, Mach N, Saiji E and Rougemont AL: Giant
cell tumor of bone with pseudosarcomatous changes leading to
premature denosumab therapy interruption: A case report with review
of the literature. Int J Surg Pathol. 24:366–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dell'Amore A, Asadi N, Caroli G, Dolci G,
Bini A and Stella F: Recurrent primary cardiac osteosarcoma: A case
report and literature review. Gen Thorac Cardiovasc Surg.
62:175–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farcas N, Arzi B and Verstraete FJ: Oral
and maxillofacial osteosarcoma in dogs: A review. Vet Comp Oncol.
12:169–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Y, Zhao RH, Tseng KF, Li KP, Lu ZG,
Liu Y, Han K, Gan ZH, Lin SC, Hu HY and Min DL: Sirolimus induces
apoptosis and reverses multidrug resistance in human osteosarcoma
cells in vitro via increasing microRNA-34b expression. Acta
Pharmacol Sin. 37:519–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao H, Peng C, Ruan G, Zhou J, Li Y and
Hai Y: Adenovirus-delivered PDCD5 counteracts adriamycin resistance
of osteosarcoma cells through enhancing apoptosis and inhibiting
Pgp. Int J Clin Exp Med. 7:5429–5436. 2014.PubMed/NCBI
|
|
9
|
Tsai HC, Huang CY, Su HL and Tang CH: CCN2
enhances resistance to cisplatin-mediating cell apoptosis in human
osteosarcoma. PLoS One. 9:e901592014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Locklin RM, Federici E, Espina B, Hulley
PA, Russell RG and Edwards CM: Selective targeting of death
receptor 5 circumvents resistance of MG-63 osteosarcoma cells to
TRAIL-induced apoptosis. Mol Cancer Ther. 6:3219–3228. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vourvouhaki E, Carvalho C and Aguiar P:
Model for Osteosarcoma-9 as a potent factor in cell survival and
resistance to apoptosis. Phys Rev E Stat Nonlin Soft Matter Phys.
76:0119262007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ozato K, Shin DM, Chang TH and Morse HC
III: TRIM family proteins and their emerging roles in innate
immunity. Nat Rev Immunol. 8:849–860. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang DX, Li K, Liu B, Zhu ZM, Xu XW, Zhao
SH, Yerle M and Fan B: Chromosomal localization, spatio-temporal
distribution and polymorphism of the porcine tripartite
motif-containing 55 (TRIM55) gene. Cytogenet Genome Res.
114:93B2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nenasheva VV, Kovaleva GV, Uryvaev LV,
Ionova KS, Dedova AV, Vorkunova GK, Chernyshenko SV, Khaidarova NV
and Tarantul VZ: Enhanced expression of trim14 gene suppressed
Sindbis virus reproduction and modulated the transcription of a
large number of genes of innate immunity. Immunol Res. 62:255–262.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kimsa MW, Strzalka-Mrozik B, Kimsa MC,
Mazurek U, Kruszniewska-Rajs C, Gola J, Adamska J and Twardoch M:
Differential expression of tripartite motif-containing family in
normal human dermal fibroblasts in response to porcine endogenous
retrovirus infection. Folia Biol (Praha). 60:144–151.
2014.PubMed/NCBI
|
|
17
|
Hassanzadeh P: Colorectal cancer and NF-κB
signaling pathway. Gastroenterol Hepatol Bed Bench. 4:127–132.
2011.PubMed/NCBI
|
|
18
|
Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng
Y, Lv J, Song Z, Li Y, Ji L, et al: Shikonin suppresses tumor
growth and synergizes with gemcitabine in a pancreatic cancer
xenograft model: Involvement of NF-κB signaling pathway. Biochem
Pharmacol. 88:322–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elghonaimy EA, Ibrahim SA, Youns A,
Hussein Z, Nouh MA, El-Mamlouk T, El-Shinawi M and Mostafa Mohamed
M: Secretome of tumor-associated leukocytes augment
epithelial-mesenchymal transition in positive lymph node breast
cancer patients via activation of EGFR/Tyr845 and NF-κB/p65
signaling pathway. Tumour Biol. 37:12441–12453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Ghonaimy EA, Ibrahim SA, Youns A,
Hussein Z, Nouh MA, El-Mamlouk T, El-Shinawi M and Mohamed MM:
Erratum to: Secretome of tumor-associated leukocytes augment
epithelial-mesenchymal transition in positive lymph node breast
cancer patients via activation of EGFR/Tyr845 and NF-kB/p65
signaling pathway. Tumour Biol. 37:143332016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu LB, Jiang J, Zhu XP, Wang TF, Chen XY,
Luo QF, Shu Y, Liu ZL and Huang SH: Knockdown of Aurora-B inhibits
osteosarcoma cell invasion and migration via modulating
PI3K/Akt/NF-kappaB signaling pathway. Int J Clin Exp Pathol.
7:3984–3991. 2014.PubMed/NCBI
|
|
22
|
Kravtsova-Ivantsiv Y and Ciechanover A:
The ubiquitin-proteasome system and activation of NF-kappaB:
Involvement of the ubiquitin ligase KPC1 in p105 processing and
tumor suppression. Mol Cell Oncol. 2:e10545522015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jamshidi M, Fagerholm R, Khan S, Aittomäki
K, Czene K, Darabi H, Li J, Andrulis IL, Chang-Claude J, Devilee P,
et al: SNP-SNP interaction analysis of NF-κB signaling pathway on
breast cancer survival. Oncotarget. 6:37979–37994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeon DG, Song WS, Cho WH, Kong CB and Cho
SH: Proximal tumor location and fluid-fluid levels on MRI predict
resistance to chemotherapy in stage IIB osteosarcoma. Clin Orthop
Relat Res. 472:1911–1920. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hagel L: Gel-filtration chromatography.
Curr Protoc Protein Sci. 8:Unit8.32001.PubMed/NCBI
|
|
27
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai FL, Yu YH, Tian H, Ren GP, Wang H,
Zhou B, Han XH, Yu QZ and Li DS: Genetically engineered Newcastle
disease virus expressing interleukin-2 and TNF-related
apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther.
15:1226–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su X, Wang J, Chen W, Li Z, Fu X and Yang
A: Overexpression of TRIM14 promotes tongue squamous cell carcinoma
aggressiveness by activating the NF-κB signaling pathway.
Oncotarget. 7:9939–9950. 2016.PubMed/NCBI
|
|
30
|
Rivoltini L, Chiodoni C, Squarcina P,
Tortoreto M, Villa A, Vergani B, Bürdek M, Botti L, Arioli I, Cova
A, et al: TNF-related apoptosis-inducing ligand (TRAIL)-armed
exosomes deliver proapoptotic signals to tumor site. Clin Cancer
Res. 22:3499–3512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai HF and Hsu PN: Modulation of tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated
apoptosis by Helicobacter pylori in immune pathogenesis of gastric
mucosal damage. J Microbiol Immunol Infect. 50:4–9. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chinchar E, Makey KL, Gibson J, Chen F,
Cole SA, Megason GC, Vijayakumar S, Miele L and Gu JW: Sunitinib
significantly suppresses the proliferation, migration, apoptosis
resistance, tumor angiogenesis and growth of triple-negative breast
cancers but increases breast cancer stem cells. Vasc Cell.
6:122014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guidicelli G, Chaigne-Delalande B,
Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier
P, Moreau JF and Legembre P: The necrotic signal induced by
mycophenolic acid overcomes apoptosis-resistance in tumor cells.
PLoS One. 4:e54932009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han J, Tian R, Yong B, Luo C, Tan P, Shen
J and Peng T: Gas6/Axl mediates tumor cell apoptosis, migration and
invasion and predicts the clinical outcome of osteosarcoma
patients. Biochem Biophys Res Commun. 435:493–500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kushlinskii NE, Solov'ev YN, Babkina IV,
Abbasova SG, Kostanyan IA, Lipkin VM and Trapeznikov NN: Leptin and
apoptosis inhibitor soluble Fas antigen in the serum of patients
with osteosarcoma and neuroectodermal bone tumors. Bull Exp Biol
Med. 129:496–498. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Zhu J, Dong M, Yu H, Dai X and Li
K: Knockdown of tripartite motif containing 24 by lentivirus
suppresses cell growth and induces apoptosis in human colorectal
cancer cells. Oncol Res. 22:39–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang T, Tang HM, Lu S, Yan DW, Yang YX
and Peng ZH: Up-regulation of tripartite motif-containing 29
promotes cancer cell proliferation and predicts poor survival in
colorectal cancer. Med Oncol. 30:7152013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han J, Yong B, Luo C, Tan P, Peng T and
Shen J: High serum alkaline phosphatase cooperating with MMP-9
predicts metastasis and poor prognosis in patients with primary
osteosarcoma in Southern China. World J Surg Oncol. 10:372012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim SM, Lee H, Park YS, Lee Y and Seo SW:
ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. J
Orthop Res. 30:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ning L, Ma H, Jiang Z, Chen L, Li L, Chen
Q and Qi H: Curcumol suppresses breast cancer cell metastasis by
inhibiting MMP-9 via JNK1/2 and Akt-dependent NF-κB signaling
pathways. Integr Cancer Ther. 15:216–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim JM, Noh EM, Kim HR, Kim MS, Song HK,
Lee M, Yang SH, Lee GS, Moon HC, Kwon KB and Lee YR: Suppression of
TPA-induced cancer cell invasion by Peucedanum japonicum Thunb.
extract through the inhibition of PKCα/NF-κB-dependent MMP-9
expression in MCF-7 cells. Int J Mol Med. 37:108–114. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han K, Chen X, Bian N, Ma B, Yang T, Cai
C, Fan Q, Zhou Y and Zhao TB: MicroRNA profiling identifies MiR-195
suppresses osteosarcoma cell metastasis by targeting CCND1.
Oncotarget. 6:8875–8889. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma
YL, Ji ZW, Li XX, Han K, Gao J, et al: miR-15a and miR-16-1
downregulate CCND1 and induce apoptosis and cell cycle arrest in
osteosarcoma. Oncol Rep. 28:1764–1770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
He N and Zhang Z: Baicalein suppresses the
viability of MG-63 osteosarcoma cells through inhibiting c-MYC
expression via Wnt signaling pathway. Mol Cell Biochem.
405:187–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weiss KR, Cooper GM, Jadlowiec JA, McGough
RL III and Huard J: VEGF and BMP expression in mouse osteosarcoma
cells. Clin Orthop Relat Res. 450:111–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang Z, Zheng Y, Zhu R, Zhu Y, Yao W, Liu
W and Gao X: The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced
osteosarcoma cells apoptosis in vitro and in vivo.
Cancer Lett. 352:203–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu X, Wang Q, Zhou X, Fu C, Cheng M, Guo
R, Liu H, Zhang B and Dai M: Celastrol negatively regulates cell
invasion and migration ability of human osteosarcoma via
downregulation of the PI3K/Akt/NF-kappaB signaling pathway in
vitro. Oncol Lett. 12:3423–3428. 2016. View Article : Google Scholar : PubMed/NCBI
|
